Skip to main content
Premium Trial:

Request an Annual Quote

Senate Confirms Lander

The Senate has confirmed Eric Lander to lead the White House Office of Science and Technology Policy in a voice vote, the Hill reports.

President Joe Biden nominated Lander, the director of the Broad Institute, to serve as science advisor, a post he elevated to a Cabinet-level position, in January. NBC News noted at the time that the change was meant to accentuate the Biden Administration's commitment to science.

During his nomination hearing, Lander faced questions about his meetings with financier and sex offender Jeffrey Epstein and his downplaying of the contributions of women in science. Lander said that his interactions with Epstein were brief and that he did not learn of his "sordid history" until later. He, meanwhile, acknowledged that he understated the roles of Jennifer Doudna and Emmanuelle Charpentier in the development of CRISPR and promised to "make full inclusion and equitable outcomes a high priority."

Politico notes, that Lander, who was confirmed Friday, was the last of President Biden's Cabinet nominees to be confirmed. Lander previously served as co-chair of the Presidential Council of Advisers on Science and Technology during the Obama Administration.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.